D-Amino acid oxidase and serine racemase in human brain: Normal distribution and altered expression in schizophrenia

European Journal of Neuroscience

Volumn 26, Issue 6, 2007, Pages 1657-1669

  Verrall, Louise ^a   Walker, Mary ^a   Rawlings, Nancy ^a   Benzel, Isabel ^b   Kew, James N C ^b   Harrison, Paul J ^a   Burnet, Philip W J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

D serine; DAAO; DAO; mRNA; SRR

Indexed keywords

DEXTRO AMINO ACID OXIDASE; HALOPERIDOL; MESSENGER RNA; RACEMASE;

ANIMAL TISSUE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; ENZYME METABOLISM; GLIA CELL; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SUBSTANTIA NIGRA; WESTERN BLOTTING; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIPSYCHOTIC AGENTS; BLOTTING, WESTERN; BRAIN; D-AMINO-ACID OXIDASE; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HALOPERIDOL; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RACEMASES AND EPIMERASES; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 34548689595     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2007.05769.x     Document Type: Article

References (87)

1. Andreasen, N.C., Paradiso, S. O'Leary, D.S. (1998) 'Cognitive dysmetria' as an integrative theory of schizophrenia: a dysfunction in cortical- subcortical-cerebellar circuitry? Schizophr. Bull., 24, 203 218.
2. Arnold, G., Liscum, L. Holtzman, E. (1979) Ultrastructural localization of d-amino acid oxidase in microperoxisomes of the rat nervous system. J. Histochem. Cytochem., 27, 735 745.
3. Bendikov, C., Nadri, S., Amar, R., Panizzutti, J., De Miranda, H., Wolosker, G. Agam,. I. (2007) A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia. Schizophr. Res., 90, 41 51.
4. Brannan, T., Prikhojan, A. Yahr, M.D. (1996) Elevated striatal dopamine levels following administration of D-DOPA and its alpha-keto acid metabolite DHPPA: behavioral and physiological studies in vivo in the rat. Brain Res., 718, 165 168.
5. Brockhaus, J. Deitmer, J.W. (2002) Long-lasting modulation of synaptic input to. Purkinje neurons by Bergmann glia stimulation in rat brain slices. J. Physiol., 545, 581 593.
6. Burnet, P.W., Michelson, D., Smith, M.A., Gold, P.W. Sternberg, E.M. (1994) The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundances of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat. Brain. Res., 638, 311 324.
7. Chumakov, I., Blumenfeld, M., Guerassimenko, O., Cavarec, L., Palicio, M., Abderrahim, H., Bougueleret, L., Barry, C., Tanaka, H., La Rosa, P., Puech, A., Tahri, N., Cohen-Akenine, A., Delabrosse, S., Lissarrague, S., Picard, F.P., Maurice, K., Essioux, L., Millasseau, P., Grel, P., Debailleul, V., Simon, A.M., Caterina, D., Dufaure, I., Malekzadeh, K., Belova, M., Luan, J.J., Bouillot, M., Sambucy, J.L., Primas, G., Saumier, M., Boubkiri, N., Martin-Saumier, S., Nasroune, M., Peixoto, H., Delaye, A., Pinchot, V., Bastucci, M., Guillou, S., Chevillon, M., Sainz-Fuertes, R., Meguenni, S., Aurich-Costa, J., Cherif, D., Gimalac, A., Van Duijn, C., Gauvreau, D., Ouellette, G., Fortier, I., Raelson, J., Sherbatich, T., Riazanskaia, N., Rogaev, E., Raeymaekers, P., Aerssens, J., Konings, F., Luyten, W., Macciardi, F., Sham, P.C., Straub, R.E., Weinberger, D.R., Cohen, N. Cohen, D. (2002) Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia. Proc. Natl. Acad. Sci. USA, 99, 13675 13680.
8. Cid, M.E. Ortega, A. (1993) Glutamate stimulates [3H]phorbol 12,13-dibutyrate binding in cultured Bergmann glia cells. Eur. J. Pharmacol., 245, 51 54.
9. Corvin, A., McGhee, K.A., Murphy, K., Donohoe, G., Nangle, J.M., Schwaiger, S., Kenny, N., Clarke, S., Meagher, D., Quinn, J., Scully, P., Baldwin, P., Browne, D., Walsh, C., Waddington, J.L., Morris, D.W. Gill, M. (2007) Evidence for association and epistasis at the DAOA/G30 and d-amino acid oxidase loci in an Irish schizophrenia sample. Am. J. Med. Genet. B Neuropsychiatr. Genet., in press.
10. Coyle, J.T. (1996) The glutamatergic dysfunction hypothesis for schizophrenia. Harv. Rev. Psychiatry, 3, 241 253.
11. De Miranda, J., Santoro, A., Engelender, S. Wolosker, H. (2000) Human serine racemase: moleular cloning, genomic organization and functional analysis. Gene, 256, 183 188.
12. Detera-Wadleigh, S.D. McMahon, F.J. (2006) G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biol. Psychiatry, 60, 106 114.
13. Dumin, E., Bendikov, I., Foltyn, V.N., Misumi, Y., Ikehara, Y., Kartvelishvily, E. Wolosker, H. (2006) Modulation of d-serine levels via ubiquitin-dependent proteasomal degradation of serine racemase. J. Biol. Chem., 281, 20291 20302.
14. Eastwood, S.L., Burnet, P.W., Gittins, R., Baker, K. Harrison, P.J. (2001a) Expression of serotonin 5-HT2A receptors in the human cerebellum and alterations in schizophrenia. Synapse, 42, 104 114.
15. Eastwood, S.L., Cairns, N.J. Harrison, P.J. (2000) Synaptophysin gene expression in schizophrenia. Investigation of synaptic pathology in the cerebral cortex. Br. J. Psychiatry, 176, 236 242.
16. Eastwood, S.L., Cotter, D. Harrison, P.J. (2001b) Cerebellar synaptic protein expression in schizophrenia. Neuroscience, 105, 219 229.
17. Eastwood, S.L., Law, A.J., Everall, I.P. Harrison, P.J. (2003) The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology. Mol. Psychiatry, 8, 148 155.
18. Foltyn, V.N., Bendikov, I., De Miranda, J., Panizzutti, R., Dumin, E., Shleper, M., Li, P., Toney, M.D., Kartvelishvily, E. Wolosker, H. (2005) Serine racemase modulates intracellular d-serine levels through an alpha,beta- elimination activity. J. Biol. Chem., 280, 1754 1763.
19. Gavazzi, E., Malgaretti, N. Curti, B. (1987) Immunochemical properties of d-amino- acid oxidase. Biochim. Biophys. Acta, 915, 188 198.
20. Goltsov, A.Y., Loseva, J.G., Andreeva, T.V., Grigorenko, A.P., Abramova, L.I., Kaleda, V.G., Orlova, V.A., Moliaka, Y.K. Rogaev, E.I. (2006) Polymorphism in the 5′-promoter region of serine racemase gene in schizophrenia. Mol. Psychiatry, 11, 325 326.
21. Hamase, K., Homma, H., Takigawa, Y., Fukushima, T., Santa, T. Imai, K. (1997) Regional distribution and postnatal changes of d-amino acids in rat brain. Biochem. Biophys. Acta, 1334, 214 222.
22. Harrison, P.J. Owen, M.J. (2003) Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet, 361, 417 419.
23. Harrison, P.J. Weinberger, D.R. (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry, 10, 40 68.
24. Hashimoto, A. (2002) Effect of the intracerebroventricular and systemic administration of L-serine on the concentrations of D- and L-serine in several brain areas and periphery of rat. Brain Res., 955, 214 220.
25. Hashimoto, K., Fukushima, T., Shimizu, E., Komatsu, N., Watanabe, H., Shinoda, N., Nakazato, M., Kumakiri, C., Okada, S., Hasegawa, H., Imai, K. Iyo, M. (2003) Decreased serum levels of d-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch. Gen. Psychiatry, 60, 572 576.
26. Hashimoto, K., Engberg, G., Shimizu, E., Nordin, C., Lindstrom, L.H. Iyo, M. (2005) Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients. Prog. Neuropsychopharmacol. Biol. Psychiatry, 29, 767 769.
27. Hashimoto, A., Oka, T. Nishikawa, T. (1995a) Anatomical distribution and postnatal changes in endogenous free d-aspartate and d-serine in rat brain and periphery. Eur. J. Neurosci., 7, 1657 1663.
28. Hashimoto, A., Oka, T. Nishikawa, T. (1995b) Extracellular concentration of endogenous free d-serine in the rat brain as revealed by in vivo microdialysis. Neuroscience, 66, 635 643.
29. Helboe, L., Egebjerg, J., Moller, M. Thomsen, C. (2003) Distribution and pharmacology of alanine-serine-cysteine transporter 1 (asc-1) in rodent brain. Eur. J. Neurosci., 18, 2227 2238.
30. Heresco-Levy, U., Javitt, D.C., Ebstein, R., Vass, A., Lichtenberg, P., Bar, G., Catinari, S. Ermilov, M. (2005) d-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia. Biol. Psychiatry, 57, 577 585.
31. Horiike, K., Tojo, H., Arai, R., Nozaki, M. Maeda, T. (1994) d-amino-acid oxidase is confined to the lower brain stem and cerebellum in rat brain: regional differentiation of astrocytes. Brain Res., 652, 297 303.
32. Horiike, K., Tojo, H., Arai, R., Yamano, T., Nozaki, M. Maeda, T. (1987) Localization of d-amino acid oxidase in Bergmann glial cells and astrocytes of rat cerebellum. Brain Res. Bull., 19, 587 596.
33. Huang, H. Bordey, A. (2004) Glial glutamate transporters limit spillover activation of presynaptic NMDA receptors and influence synaptic inhibition of Purkinje neurons. J. Neurosci., 24, 5659 5669.
34. Ito, K. Hicks, T.P. (2001) Effect of the glycine modulatory site of the N-methyl-D- aspartate receptor on synaptic responses in kitten visual cortex. Neurosci. Lett., 303, 95 98.
35. Kapoor, R., Lim, K.S., Cheng, A., Garrick, T. Kapoor, V. (2006) Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, D-amino acid oxidase (DAO) and kynurenine aminotransferase-1 (KAT-1). Brain Res., 1106, 205 210.
36. Kartvelishvily, E., Shleper, M., Balan, L., Dumin, E. Wolosker, H. (2006) Neuron- derived d-serine release provides a novel means to activate N-methyl-D-aspartate receptors. J. Biol. Chem., 281, 14151 14162.
37. Katagiri, M., Tojo, H., Horiike, K. Yamano, T. (1991) Immunochemical relationship of d-amino acid oxidases in various tissues and animals. Comp. Biochem. Physiol. B, 99, 345 350.
38. Katsetos, C.D., Hyde, T.M. Herman, M. (1997) Neuropathology of the cerebellum in schizophrenia - An update: 1996 and future directions. Biol. Psychiatry., 42, 213 224.
39. Kawazoe, T., Tsuge, H., Imagawa, T., Aki, K., Kuramitsu, S. Fukui, K. (2007) Structural basis of D-DOPA oxidation by D-amino acid oxidase: alternative pathway for dopamine biosynthesis. Biochem. Biophys. Res. Commun, 355, 385 391.
40. Konarski, J.Z., McIntyre, R.S., Grupp, L.A. Kennedy, S.H. (2005) Is the cerebellum relevant in the circuitry of neuropsychiatric disorders? J. Psychiatry Neurosci., 30, 178 186.
41. Korostishevsky, M., Kaganovich, M., Cholostoy, A., Ashkenazi, M., Ratner, Y., Dahary, D., Bernstein, J., Bening-Abu-Shach, U., Ben-Asher, E., Lancet, D., Ritsner, M. Navon, R. (2004) Is the G72/G30 locus associated with schizophrenia? single nucleotide polymorphisms, haplotypes, and gene expression analysis. Biol. Psychiatry, 56, 169 176.
42. Kumashiro, S., Hashimoto, A. Nishikawa, T. (1995) Free d-serine in post-mortem brains and spinal cords of individuals with and without neuropsychiatric diseases. Brain Res., 681, 117 125.
43. Laruelle, M., Kegeles, L.S. Abi-Dargham, A. (2003) Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Ann. NY Acad. Sci., 1003, 138 158.
44. Law, A.J., Hutchinson, L.J., Burnet, P.W. Harrison, P.J. (2004) Antipsychotics increase microtubule-associated protein 2 mRNA but not spinophilin mRNA in rat hippocampus and cortex. J. Neurosci. Res., 76, 376 382.
45. Law, A.J., Kleinman, J.E., Weinberger, D.R. Weickert, C.S. (2007) Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum. Mol. Genet., 16, 129 141.
46. Law, A.J., Lipska, B.K., Weickert, C.S., Hyde, T.M., Straub, R., Hashimoto, R., Harrison, P.J., Kleinman, J.E. Weinberger, D.R. (2006) Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′-SNPs associated with the disease. Proc. Natl Acad. Sci. USA, 103, 6747 6752.
47. Li, D. He, L. (2007) G72/G30 genes and schizophrenia: a systematic meta-analysis of association studies. Genetics, 175, 917 922.
48. Liu, Y.L., Fann, C.S., Liu, C.M., Chang, C.C., Wu, J.Y., Hung, S.I., Liu, S.K., Hsieh, M.H., Hwang, T.J., Chan, H.Y., Chen, J.J., Faraone, S.V., Tsuang, M.T., Chen, W.J. Hwu, H.G. (2006) No association of G72 and d-amino acid oxidase genes with schizophrenia. Schizophr. Res., 87, 15 20.
49. Liu, X., He, G., Wang, X., Chen, Q., Qian, X., Lin, W., Li, D., Gu, N., Feng, G. He, L. (2004) Association of DAO with schizophrenia in the Chinese population. Neurosci. Lett., 369, 228 233.
50. Matsuo, H., Kanai, Y., Tokunaga, M., Nakata, T., Chairoungdua, A., Ishimine, H., Tsukada, S., Ooigawa, H., Nawashiro, H., Kobayashi, Y., Fukuda, J. Endou, H. (2004) High affinity - and - serine transporter Asc-1: cloning and dendritic localization in the rat cerebral and cerebellar cortices. Neurosci. Lett., 358, 123 126.
51. Moghaddam, B. (2003) Bringing order to the glutamate chaos in schizophrenia. Neuron, 40, 881 884.
52. Moreno, S., Nardacci, R., Cimini, A. Ceru, M.P. (1999) Immunocytochemical localization of d-amino acid oxidase in rat brain. J. Neurocytol., 28, 169 185.
53. Morikawa, A., Hamase, K., Inoue, T., Konno, R., Niwa, A. Zaitsu, K. (2001) Determination of free d-aspartic acid, d-serine and d-alanine in the brain of mutant mice lacking d-amino acid oxidase activity. J. Chromatogr. B Biomed. Sci. Appl., 757, 119 125.
54. Morita, Y., Ujike, H., Tanaka, Y., Otani, K., Kishimoto, M., Morio, A., Kotaka, T., Okahisa, Y., Matsushita, M., Morikawa, A., Hamase, K., Zaitsu, K. Kuroda, S. (2007) A genetic variant of the serine racemase gene is associated with schizophrenia. Biol. Psychiatry, 61, 1200 1203.
55. Moses, J., Siddiqui, A. Silverman, P.B. (1996) Sodium benzoate differentially blocks circling induced by d-and l-dopa in the hemi-parkinsonian rat. Neurosci. Lett., 218, 145 148.
56. Mothet, J.P., Parent, A.T., Wolosker, H., Brady, R.O. Jr., Linden, D.J., Ferris, C.D., Rogawski, M.A. Snyder, S.H. (2000) d-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. USA, 97, 4926 4931.
57. Nagata, Y., Horiike, K. Maeda, T. (1994) Distribution of free d-serine in vertebrate brains. Brain Res., 634, 291 295.
58. Olney, J.W. Farber, N.B. (1995) Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry, 52, 998 1007.
59. Pollegioni, L., Piubelli, L., Sacchi, S., Pilone, M.S. Molla, G. (2007) Physiological functions of d-amino acid oxidases: from yeast to humans. Cell Mol. Life Sci., 64, 1373 1394.
60. Rutter, R., Fradley, R., Garrett, E., Chapman, K., Lawrence, J., Rosahl, T. Patel, S. (2007) Evidence from gene knockout studies implicates Asc-1 as the primary transporter mediating d-serine reuptake in the mouse CNS. Eur. J. Neurosci., 25, 1757 1766.
61. Schell, M.J., Brady, R.O. Jr., Molliver, M.E. Snyder, S.H. (1997) d-serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors. J. Neurosci., 17, 1604 1615.
62. Schell, M.J., Molliver, M.E. Snyder, S.H. (1995) d-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc. Natl. Acad. Sci. USA, 92, 3948 3952.
63. Schumacher, J., Jamra, R.A., Freudenberg, J., Becker, T., Ohlraun, S., Otte, A.C., Tullius, M., Kovalenko, S., Bogaert, A.V., Maier, W., Rietschel, M., Propping, P., Nothen, M.M. Cichon, S. (2004) Examination of G72 and d-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol. Psychiatry, 9, 203 207.
64. Shleper, M., Kartvelishvily, E. Wolosker, H. (2005) d-serine is the dominant endogenous coagonist for NMDA receptor neurotoxicity in organotypic hippocampal slices. J. Neurosci., 25, 9413 9417.
65. Steffek, A.E., Haroutunian, V. Meador-Woodruff, J.H. (2006) Serine racemase protein expression in cortex and hippocampus in schizophrenia. Neuroreport, 17, 1181 1185.
66. Strisovsky, K., Jiraskova, J., Mikulova, A., Rulisek, L. Konvalinka, J. (2005) Dual substrate and reaction specificity in mouse serine racemase: identification of high-affinity dicarboxylate substrate and inhibitors and analysis of the beta-eliminase activity. Biochemistry, 44, 13091 13100.
67. Strohmaier, J., Georgi, A., Schirmbeck, F., Schmael, C., Jamra, R.A., Schumacher, J., Becker, T., Hofels, S., Klopp, N., Illig, T., Propping, P., Cichon, S., Nothen, M.M., Rietschel, M. Schulze, T.G. (2007) No association between the serine racemase gene (SRR) and schizophrenia in a German case-control sample. Psychiatr. Genet., 17, 125 129.
68. Thiels, E., Weisz, D.J. Berger, T.W. (1992) In vivo modulation of N-methyl-D-aspartate receptor-dependent long-term potentiation by the glycine modulatory site. Neuroscience, 46, 501 509.
69. Tsai, G., Yang, P., Chung, L.C., Lange, N. Coyle, J.T. (1998) d-serine added to antipsychotics for the treatment of schizophrenia. Biol. Psychiatry, 44, 1081 1089.
70. Vilella, E., Costas, J., Sanjuan, J., Guitart, M., De Diego, Y., Carracedo, A., Martorell, L., Valero, J., Labad, A., De Frutos, R., Najera, C., Molto, M.D., Toirac, I., Guillamat, R., Brunet, A., Valles, V., Perez, L., Leon, M., de Fonseca, F.R., Phillips, C. Torres, M. (2007) Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction. J. Psychiatr. Res., in press.
71. Wang, L.Z. Zhu, X.Z. (2003) Spatiotemporal relationships among d-serine, serine racemase, and d-amino acid oxidase during mouse postnatal development. Acta Pharmacol. Sin., 24, 965 974.
72. Williams, S.M., Diaz, C.M., Macnab, L.T., Sullivan, R.K. Pow, D.V. (2006) Immunocytochemical analysis of d-serine distribution in the mammalian brain reveals novel anatomical compartmentalizations in glia and neurons. Glia, 53, 401 411.
73. Wolosker, H., Blackshaw, S. Snyder, S.H. (1999a) Serine racemase: a glial enzyme synthesizing d-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. Proc. Natl Acad. Sci. USA, 96, 13409 13414.
74. Wolosker, H., Sheth, K.N., Takahashi, M., Mothet, J.P., Brady, R.O. Jr., Ferris, C.D. Snyder, S.H. (1999b) Purification of serine racemase: biosynthesis of the neuromodulator d-serine. Proc. Natl Acad. Sci. USA, 96, 721 725.
75. Wood, L.S., Pickering, E.H. Dechairo, B.M. (2007) Significant support for DAO as a schizophrenia susceptibility locus: examination of five genes putatively associated with schizophrenia. Biol. Psychiatry., 61, 1195 1199.
76. Wu, S. Barger, S.W. (2004) Induction of serine racemase by inflammatory stimuli is dependent on AP-1. Ann. NY Acad. Sci., 1035, 133 146.
77. Wu, M., Zhou, X.J., Konno, R. Wang, Y.X. (2006) d-dopa is unidirectionally converted to l-dopa by d-amino acid oxidase, followed by dopa transaminase. Clin. Exp. Pharmacol. Physiol., 33, 1042 1046.
78. Xia, M., Liu, Y., Figueroa, D.J., Chiu, C.S., Wei, N., Lawlor, A.M., Lu, P., Sur, C., Koblan, K.S. Connolly, T.M. (2004) Characterization and localization of a human serine racemase. Brain Res. Mol. Brain Res., 125, 96 104.
79. Yagi, K., Nagatsu, T. Ozawa, T. (1956) Inhibitory action of chlorpromazine on the oxidation of d-amino-acid in the diencephalon part of the brain. Nature, 177, 891 892.
80. Yamada, K., Ohnishi, T., Hashimoto, K., Ohba, H., Iwayama-Shigeno, Y., Toyoshima, M., Okuno, A., Takao, H., Toyota, T., Minabe, Y., Nakamura, K., Shimizu, E., Itokawa, M., Mori, N., Iyo, M. Yoshikawa, T. (2005) Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and d-serine levels. Biol. Psychiatry, 57, 1493 1503.
81. Yang, Y., Ge, W., Chen, Y., Zhang, Z., Shen, W., Wu, C., Poo, M. Duan, S. (2003) Contribution of astrocytes to hippocampal long-term potentiation through release of d-serine. Proc. Natl Acad. Sci. USA, 100, 15194 15199.
82. Yasuda, E., Ma, N. Semba, R. (2001) Immunohistochemical evidences for localization and production of d-serine in some neurons in the rat brain. Neurosci. Lett., 299, 162 164.
83. Yoshikawa, M., Kobayashi, T., Oka, T., Kawaguchi, M. Hashimoto, A. (2004a) Distribution and MK-801-induced expression of serine racemase mRNA in rat brain by real-time quantitative PCR. Brain Res. Mol. Brain Res., 128, 90 94.
84. Yoshikawa, M., Nakajima, K., Takayasu, N., Noda, S., Sato, Y., Kawaguchi, M., Oka, T., Kobayashi, H. Hashimoto, A. (2006) Expression of the mRNA and protein of serine racemase in primary cultures of rat neurons. Eur. J. Pharmacol., 548, 74 76.
85. Yoshikawa, M., Oka, T., Kawaguchi, M. Hashimoto, A. (2004b) MK-801 upregulates the expression of d-amino acid oxidase mRNA in rat brain. Brain Res. Mol. Brain Res., 131, 141 144.
86. Yue, W., Kang, G., Zhang, Y., Qu, M., Tang, F., Han, Y., Ruan, Y., Lu, T., Zhang, J. Zhang, D. (2007) Association of DAOA polymorphisms with schizophrenia and clinical symptoms or therapeutic effects. Neurosci. Lett., 416, 96 100.
87. Zaar, K., Kost, H.P., Schad, A., Volkl, A., Baumgart, E. Fahimi, H.D. (2002) Cellular and subcellular distribution of d-aspartate oxidase in human and rat brain. J. Comp. Neurol., 450, 272 282.